Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Zito

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Pediatrics|January 1, 1996
Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy GroupM B Rennels, R I Glass, P H Dennehy, et al.
The Journal of Infection|August 14, 2016
Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 studyHelen Marshall, Michael Nissen, Peter Richmond, et al.
The Journal of Infection|October 5, 2019
S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccineHelen S Marshall, James Baber, Peter Richmond, et al.
Vaccine|February 25, 2015
A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adultsMichael Nissen, Helen Marshall, Peter Richmond, et al.
Vaccine|November 22, 2016
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trialC Buddy Creech, Robert W Frenck, Eric A Sheldon, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Pediatrics|January 1, 1996
Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy GroupM B Rennels, R I Glass, P H Dennehy, et al.
The Journal of Infection|August 14, 2016
Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 studyHelen Marshall, Michael Nissen, Peter Richmond, et al.
The Journal of Infection|October 5, 2019
S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccineHelen S Marshall, James Baber, Peter Richmond, et al.
Vaccine|February 25, 2015
A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adultsMichael Nissen, Helen Marshall, Peter Richmond, et al.
Vaccine|November 22, 2016
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trialC Buddy Creech, Robert W Frenck, Eric A Sheldon, et al.
Pageof 2